Aion Therapeutic ROE 2024

Aion Therapeutic Aktienanalyse

What does Aion Therapeutic do?

Aion Therapeutic Inc is a Canadian company specializing in the development of medications derived from cannabis and the research of these compounds. The company was founded in 2017 and has been operating on the Toronto Stock Exchange under the ticker symbol AION. The goal of Aion Therapeutic is to advance the development of innovative therapies based on the medical application of cannabinoids. The company focuses on discovering and testing medications that not only have high efficacy but also have a lower risk of side effects. Aion Therapeutic's business model is built on several pillars. This includes research and development of medications based on cannabis compounds such as CBD and THC. The company works closely with experts in the field of science and cannabinoid pharmaceutical production. Another important area is the distribution of cannabis products, such as seeds, oils, extracts, and dried flowers. The company utilizes innovative technologies and processes to improve the quality and effectiveness of these products. In terms of its business activities, Aion Therapeutic can be divided into different areas. One of the most important is the development of medications based on cannabis extract chemotypes that can be used for the prevention and treatment of diseases such as pain, inflammation, chronic conditions, and neurological disorders. The company collaborates closely with leading research institutes and universities worldwide to focus on developing methods that improve the effectiveness and safety of these products. Aion Therapeutic is also active in the manufacturing and marketing of cannabis products. The company offers high-quality cannabinoid extracts from different hemp varieties, specifically tailored to meet the needs of medical users. These products aim to enhance users' well-being and alleviate symptoms of chronic conditions. Another important area of Aion Therapeutic is the application of cannabis-based products in veterinary medicine. The company focuses on developing veterinary medicines specifically designed for pets such as dogs and cats. Similar to the medical application of CBD and THC in humans, the use in veterinary medicine aims to alleviate chronic pain and inflammation or enhance well-being. In summary, Aion Therapeutic is a company specializing in the development of cannabis-based medications and products. With a focus on new technologies and research findings, the company aims to improve the medical application of CBD and THC and establish them as a credible alternative to conventional medications. Aion Therapeutic ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Aion Therapeutic's Return on Equity (ROE)

Aion Therapeutic's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Aion Therapeutic's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Aion Therapeutic's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Aion Therapeutic’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Aion Therapeutic stock

What is the ROE (Return on Equity) of Aion Therapeutic this year?

The ROE of Aion Therapeutic this year is 0.1 undefined.

How has the Return on Equity (ROE) of Aion Therapeutic developed compared to the previous year?

The ROE of Aion Therapeutic has increased by -93.99% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Aion Therapeutic?

A high ROE indicates that Aion Therapeutic generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Aion Therapeutic?

A low ROE can indicate that Aion Therapeutic is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Aion Therapeutic affect the company?

A change in ROE (Return on Equity) of Aion Therapeutic can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Aion Therapeutic?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Aion Therapeutic?

Some factors that can influence Aion Therapeutic's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Aion Therapeutic pay?

Over the past 12 months, Aion Therapeutic paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Aion Therapeutic is expected to pay a dividend of 0 CAD.

What is the dividend yield of Aion Therapeutic?

The current dividend yield of Aion Therapeutic is .

When does Aion Therapeutic pay dividends?

Aion Therapeutic pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Aion Therapeutic?

Aion Therapeutic paid dividends every year for the past 0 years.

What is the dividend of Aion Therapeutic?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Aion Therapeutic located?

Aion Therapeutic is assigned to the '-' sector.

Wann musste ich die Aktien von Aion Therapeutic kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Aion Therapeutic from 9/26/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 9/26/2024.

When did Aion Therapeutic pay the last dividend?

The last dividend was paid out on 9/26/2024.

What was the dividend of Aion Therapeutic in the year 2023?

In the year 2023, Aion Therapeutic distributed 0 CAD as dividends.

In which currency does Aion Therapeutic pay out the dividend?

The dividends of Aion Therapeutic are distributed in CAD.